96 related articles for article (PubMed ID: 27270651)
21. Platelet activation is associated with myocardial infarction in patients with pneumonia.
Cangemi R; Casciaro M; Rossi E; Calvieri C; Bucci T; Calabrese CM; Taliani G; Falcone M; Palange P; Bertazzoni G; Farcomeni A; Grieco S; Pignatelli P; Violi F; ;
J Am Coll Cardiol; 2014 Nov; 64(18):1917-25. PubMed ID: 25444147
[TBL] [Abstract][Full Text] [Related]
22. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage.
van Kooten F; Ciabattoni G; Koudstaal PJ; Dippel DW; Patrono C
Stroke; 1999 Mar; 30(3):546-9. PubMed ID: 10066850
[TBL] [Abstract][Full Text] [Related]
23. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
[TBL] [Abstract][Full Text] [Related]
24. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.
Ghanbari H; Başer K; Jongnarangsin K; Chugh A; Nallamothu BK; Gillespie BW; Başer HD; Suwanagool A; Crawford T; Latchamsetty R; Good E; Pelosi F; Bogun F; Morady F; Oral H
Heart Rhythm; 2014 Sep; 11(9):1503-11. PubMed ID: 24813379
[TBL] [Abstract][Full Text] [Related]
25. Aspirin response: Differences in serum thromboxane B2 levels between clinical studies.
Brun C; Daali Y; Combescure C; Zufferey A; Michelson AD; Fontana P; Reny JL; Frelinger AL
Platelets; 2016; 27(3):196-202. PubMed ID: 26270593
[TBL] [Abstract][Full Text] [Related]
26. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
27. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Eikelboom JW; Hankey GJ; Thom J; Bhatt DL; Steg PG; Montalescot G; Johnston SC; Steinhubl SR; Mak KH; Easton JD; Hamm C; Hu T; Fox KA; Topol EJ;
Circulation; 2008 Oct; 118(17):1705-12. PubMed ID: 18838564
[TBL] [Abstract][Full Text] [Related]
28. Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation?
Pastori D; Carnevale R; Bartimoccia S; Nocella C; Tanzilli G; Cangemi R; Vicario T; Catena M; Violi F; Pignatelli P
Antioxid Redox Signal; 2015 Sep; 23(8):682-7. PubMed ID: 25825798
[TBL] [Abstract][Full Text] [Related]
29. Determinants of platelet activation in human essential hypertension.
Minuz P; Patrignani P; Gaino S; Seta F; Capone ML; Tacconelli S; Degan M; Faccini G; Fornasiero A; Talamini G; Tommasoli R; Arosio E; Santonastaso CL; Lechi A; Patrono C
Hypertension; 2004 Jan; 43(1):64-70. PubMed ID: 14656953
[TBL] [Abstract][Full Text] [Related]
30. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1726-30. PubMed ID: 22761461
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance as a determinant of platelet activation in obese women.
Basili S; Pacini G; Guagnano MT; Manigrasso MR; Santilli F; Pettinella C; Ciabattoni G; Patrono C; Davì G
J Am Coll Cardiol; 2006 Dec; 48(12):2531-8. PubMed ID: 17174194
[TBL] [Abstract][Full Text] [Related]
32. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Choudhury A; Chung I; Blann AD; Lip GYH
Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
[TBL] [Abstract][Full Text] [Related]
33. [Changes in plasma TXB2 and 6-keto-PGF1 alpha and left atrial thrombosis in mitral stenosis].
Cai W
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):98-100, 127. PubMed ID: 2209410
[TBL] [Abstract][Full Text] [Related]
34. Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study.
Menichelli D; Carnevale R; Nocella C; Cammisotto V; Castellani V; Bartimoccia S; Frati G; Pignatelli P; Pastori D
Front Cardiovasc Med; 2021; 8():779503. PubMed ID: 34869693
[No Abstract] [Full Text] [Related]
35. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
36. Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.
Guo Y; Apostalakis S; Blann AD; Lip GY
Cerebrovasc Dis; 2014; 38(3):204-11. PubMed ID: 25301077
[TBL] [Abstract][Full Text] [Related]
37. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
[TBL] [Abstract][Full Text] [Related]
38. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Vasiljevic ZM; Vujisic-Tesic BD; Marinkovic JM; Polovina MM; Stepanovic JM; Stankovic GR; Ostojic MC; Lip GYH
Chest; 2011 Oct; 140(4):902-910. PubMed ID: 21436252
[TBL] [Abstract][Full Text] [Related]
39. Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation.
Lim HS; Willoughby SR; Schultz C; Chakrabarty A; Alasady M; Lau DH; Roberts-Thomson KC; Worthley MI; Young GD; Sanders P
Heart Rhythm; 2014 Nov; 11(11):1912-8. PubMed ID: 25068571
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.
Verdecchia P; Dagenais G; Healey J; Gao P; Dans AL; Chazova I; Binbrek AS; Iacobellis G; Ferreira R; Holwerda N; Karatzas N; Keltai M; Mancia G; Sleight P; Teo K; Yusuf S;
J Hypertens; 2012 May; 30(5):1004-14. PubMed ID: 22495138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
